You are right Kitty. Now is the time to back up the truck. The financings put a lot of short term $$ in this company. Traders with little understanding of biotech came to play the results. They don't want to wait a year for approval and for some visibility on secondary indications.
Show a little patience and this is as about a sure term double in a year or two as you can find. The main worries now are simply macroeconomic.